Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders

US9822102B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Susanne Röhrig · Hilden, DE
• Alexander Hillisch · Solingen, DE
• Julia Strassburger · Wuppertal, DE
• Stefan Heitmeier · Wülfrath, DE
• Martina Victoria Schmidt
• Karl-Heinz Schlemmer · Wuppertal, DE
• Adrian Tersteegen · Wuppertal, DE
• Anja Buchmüller · Essen, DE
• Christoph Gerdes
• Martina Schäfer · Berlin, DE
• Tom KINZEL · Mülheim an der Ruhr, DE
• Henrik Teller · Schwaan, DE
• Hartmut Schirok · Wuppertal, DE
• Jürgen Klar · Wuppertal, DE
• Eloisa Jimenez Nunez · Wuppertal, DE

Key dates

• Filing date: Sep 4, 2016
• Grant date: Nov 21, 2017
• Expiry date: Sep 4, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/05
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.